adu-1805
Showing 1 - 1 of 1
Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer Trial (ADU-1805, Pembrolizumab)
Not yet recruiting
- Solid Tumor, Adult
- +2 more
- ADU-1805
- Pembrolizumab
- (no location specified)
May 3, 2023